Showing results (1001-1010 of 11,327) with videos related to

Sort By:
Pageof 1,133
Thrombosis and Haemostasis|August 1, 1995
Chrono-pharmacological study of once daily curative dose of a low molecular weight heparin (200 IU antiXa/kg of Dalteparin) in ten healthy volunteersP Mismetti, J Reynaud, B Tardy-Ponce, et al.
Thrombosis and Haemostasis|August 1, 1995
Comparison of immunological and functional assays for measurement of soluble fibrinC E Dempfle, S A Pfitzner, M Dollman, et al.
Thrombosis and Haemostasis|August 1, 1995
Haemostatic effects of supraphysiological levels of testosterone in normal menR A Anderson, C A Ludlam, F C Wu
Thrombosis and Haemostasis|August 1, 1995
Increased expression of inducible cyclooxygenase-2 in human endothelial cells by antiphospholipid antibodiesA Habib, M E Martinuzzo, L O Carreras, et al.
Thrombosis and Haemostasis|August 1, 1995
The reproductive health of women with von Willebrand Disease unresponsive to DDAVP: results of an international survey. On behalf of the Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the ISTHP A Foster
Thrombosis and Haemostasis|April 1, 1996
Elevated fibrinopeptide A and B levels during thrombolytic therapy: real or artefactual?J I Weitz
Thrombosis and Haemostasis|April 1, 1996
Evaluation of a soluble fibrin assay in patients with suspected pulmonary embolismJ S Ginsberg, S Siragusa, J Douketis, et al.
Thrombosis and Haemostasis|April 1, 1996
Inhibition of protein S by autoantibodies in patients with acquired protein S deficiencyM Sorice, P Arcieri, T Griggi, et al.
Thrombosis and Haemostasis|April 1, 1996
Prothrombin time sensitivity and specificity to mild clotting factor deficiencies of the extrinsic pathway: evaluation of eight commercial thromboplastinsD Massignon, M Moulsma, P Bondon, et al.
Thrombosis and Haemostasis|April 1, 1996
Monoclonal antibodies to human fibrin: interaction with other animal fibrinsT Edgell, F McEvoy, P Webbon, et al.
Pageof 1,133